Pseudomonas aeruginosa Lipid A Structural Variants Induce Altered Immune Responses
- 1 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 71 (2) , 207-218
Abstract
Pseudomonas aeruginosa causes chronic lung infection in cystic fibrosis (CF), resulting in structural lung damage and progressive pulmonary decline. P. aeruginosa in the CF lung undergoes numerous changes, adapting to host-specific airway pressures while establishing chronic infection. P. aeruginosa undergoes lipid A structural modification during CF chronic infection that is not seen in any other disease state. Lipid A, the membrane anchor of LPS (i.e., endotoxin), comprises the majority of the outer membrane of Gram-negative bacteria and is a potent Toll-like receptor 4 (TLR4) agonist. The structure of P. aeruginosa lipid A is intimately linked with its recognition by TLR4 and subsequent immune response. Prior work has identified P. aeruginosa strains with altered lipid A structures that arise during chronic CF lung infection; however, the impact of the P. aeruginosa lipid A structure on airway disease has not been investigated. Here, we show that P. aeruginosa lipid A lacks PagL-mediated deacylation during human airway infection using a direct-from-sample mass spectrometry approach on human BAL fluid. This structure triggers increased proinflammatory cytokine production by primary human macrophages. Furthermore, alterations in lipid A 2-hydroxylation impact cytokine response in a site-specific manner, independent of CF transmembrane conductance regulator function. It is interesting that there is a CF-specific reduction in IL-8 secretion within the epithelial-cell compartment that only occurs in CF bronchial epithelial cells when infected with CF-adapted P. aeruginosa that lacks PagL-mediated lipid A deacylation. Taken together, we show that P. aeruginosa alters its lipid A structure during acute lung infection and that this lipid A structure induces stronger signaling through TLR4.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (T32HL007586)
- National Institute of Allergy and Infectious Diseases (R01Al104895)
- National Institute of Allergy and Infectious Diseases (R01Al147314)
- National Institute of Allergy and Infectious Diseases (T32AI162579)
- Cystic Fibrosis Foundation (HOFSTA23H0)
- Cystic Fibrosis Foundation (ERNST23G0)
- National Heart, Lung, and Blood Institute (T32HL007586)
- National Institute of Allergy and Infectious Diseases (R01Al104895)
- National Institute of Allergy and Infectious Diseases (R01Al147314)
- National Institute of Allergy and Infectious Diseases (T32AI162579)
- Cystic Fibrosis Foundation (HOFSTA23H0)
- Cystic Fibrosis Foundation (ERNST23G0)
This publication has 48 references indexed in Scilit:
- Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm FormationCell Metabolism, 2020
- Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa ImmunityImmunity, 2017
- Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationshipBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis LungsCell Host & Microbe, 2015
- Recognition of lipopolysaccharide pattern by TLR4 complexesExperimental & Molecular Medicine, 2013
- Conformationally Constrained Lipid A Mimetics for Exploration of Structural Basis of TLR4/MD-2 Activation by LipopolysaccharideACS Chemical Biology, 2013
- Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patientsBiochemical and Biophysical Research Communications, 2012
- Lipid A Receptor TLR4-Mediated Signaling Pathways2009
- Cystic fibrosis: recent structural insightsJournal of Cystic Fibrosis, 2004
- Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistencePaediatric Respiratory Reviews, 2002